Pakdel Farzad, Zand Amin, Sharifi Ali, Asadi Masih, Abri Aghdam Kaveh
Department of Oculo-Facial Plastic Surgery, Department of Ophthalmology, Farabi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Department of Ophthalmology, Shafa Hospital, Kerman University of Medical Sciences, Kerman, Iran.
J Ophthalmic Vis Res. 2022 Aug 15;17(3):424-431. doi: 10.18502/jovr.v17i3.11582. eCollection 2022 Jul-Sep.
Secondary infections in hospitalized and ill patients with coronavirus disease 2019 (COVID-19) are common. One of these life-threatening infectious diseases is rhino-orbital mucormycosis, which made an outbreak recently. This outbreak was mainly caused by the administration of high-dose corticosteroids in patients with COVID-19, especially those with diabetes mellitus. The increased incidence of rhino-orbital mucormycosis in the COVID-19 era presents different challenges for healthcare providers including ophthalmologists who are directly involved in disease management. We summarized the main challenges and recommendations for ophthalmologists on the management of rhino-orbital mucormycosis.
2019冠状病毒病（COVID-19）住院患者和患病患者的继发感染很常见。其中一种危及生命的传染病是鼻眶毛霉病，该病最近爆发。此次爆发主要是由COVID-19患者，尤其是糖尿病患者使用大剂量皮质类固醇引起的。COVID-19时代鼻眶毛霉病发病率的增加给包括直接参与疾病管理的眼科医生在内的医疗服务提供者带来了不同的挑战。我们总结了眼科医生在鼻眶毛霉病管理方面的主要挑战和建议。
